Atlantic Health Partners | Vaccine Program Partner | MassAFP

The HPV Vaccine: Expanding Its Role in Cancer Prevention

When the human papilloma virus (HPV) vaccine was first introduced in 2006, the primary purpose was to prevent cervical cancer caused by HPV in pre-teen girls and young women. Since then, the vaccine has proven to serve a broader community and recognized to prevent six types of cancer by the Center for Disease Control and Prevention (CDC).

Most recently, in June 2020, the U.S. Food & Drug Administration (FDA) approved the HPV vaccine, Gardasil 9, to prevent oropharyngeal and other head and neck cancers caused by HPV. Particularly as in-person care visits resume, providers have an opportunity to help patients catch up on preventative care measures they may have missed during the pandemic, including the HPV vaccine.

Sign up to the
MASSAFP Email List